14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £141.16 £183.01 Thursday, 8th Feb 2024 ERGO.L stock ended at £1,346.00. During the day the stock fluctuated 0% from a day low at £1,346.00 to a day high of £1,346.00.
90 days £141.16 £227.30
52 weeks £84.73 £227.30

Historical Entia Biosciences Inc prices

Date Open High Low Close Volume
Oct 06, 2023 £1,338.00 £1,348.00 £1,321.80 £1,342.00 122 158
Oct 05, 2023 £1,338.00 £1,338.00 £1,338.00 £1,338.00 0
Oct 04, 2023 £1,350.00 £1,350.00 £1,338.00 £1,338.00 606 614
Oct 03, 2023 £1,342.00 £1,348.00 £1,342.00 £1,344.00 730 305
Oct 02, 2023 £1,342.00 £1,342.00 £1,342.00 £1,342.00 0
Sep 29, 2023 £1,348.00 £1,348.00 £1,322.00 £1,342.00 568 056
Sep 28, 2023 £1,344.00 £1,346.00 £1,342.00 £1,342.00 861 503
Sep 27, 2023 £1,342.00 £1,348.00 £1,342.00 £1,344.00 546 585
Sep 26, 2023 £1,350.00 £1,350.00 £1,344.00 £1,344.00 1 955 921
Sep 25, 2023 £1,350.00 £1,352.00 £1,346.00 £1,348.00 388 650
Sep 22, 2023 £1,352.00 £1,356.00 £1,342.00 £1,342.00 1 140 249
Sep 21, 2023 £1,350.00 £1,356.00 £1,350.00 £1,356.00 98 003
Sep 20, 2023 £1,352.00 £1,354.00 £1,350.00 £1,350.00 557 603
Sep 19, 2023 £1,352.00 £1,354.00 £1,350.00 £1,350.00 253 709
Sep 18, 2023 £1,350.00 £1,356.00 £1,350.00 £1,354.00 631 791
Sep 15, 2023 £1,358.00 £1,358.00 £1,350.00 £1,350.00 270 758
Sep 14, 2023 £1,356.00 £1,356.00 £1,350.00 £1,350.00 1 486 881
Sep 13, 2023 £1,350.60 £1,356.00 £1,350.00 £1,350.00 421 123
Sep 12, 2023 £1,350.48 £1,356.00 £1,350.00 £1,352.00 289 296
Sep 11, 2023 £1,352.00 £1,374.00 £1,350.00 £1,350.00 639 533
Sep 08, 2023 £1,352.00 £1,358.00 £1,350.00 £1,350.00 463 190
Sep 07, 2023 £1,350.00 £1,350.00 £1,350.00 £1,350.00 0
Sep 06, 2023 £1,350.00 £1,356.00 £1,350.00 £1,350.00 1 590 326
Sep 05, 2023 £1,346.00 £1,352.00 £1,346.00 £1,350.00 1 283 212
Sep 04, 2023 £1,328.00 £1,378.00 £1,325.00 £1,348.00 6 489 334
Click to get the best stock tips daily for free!

About Entia Biosciences Inc

Entia Biosciences Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance service... ERGO.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT